Federated Hermes, Inc. Idera Pharmaceuticals, Inc. Transaction History

Federated Hermes, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.32 - $0.74 $598 - $1,383	-1,870 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.01 - $1.58 $180 - $282	179 Added 10.59%	1,870 $2,000
Q1 2021 May 13, 2021	BUY	$1.23 - $5.98 $1,166 - $5,669	948 Added 127.59%	1,691 $2,000
Q4 2020 Feb 12, 2021	BUY	$2.09 - $5.18 $449 - $1,113	215 Added 40.72%	743 $3,000
Q3 2020 Nov 12, 2020	BUY	$1.71 - $2.68 $902 - $1,415	528 New	528 $1,000
Q1 2020 May 13, 2020	SELL	$1.06 - $2.15 $114 - $232	-108 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$1.45 - $2.79 $285 - $549	-197 Reduced 64.59%	108 $1,000
Q3 2019 Nov 14, 2019	SELL	$2.12 - $3.31 $5,444 - $8,500	-2,568 Reduced 89.38%	305 $1,000
Q1 2019 May 10, 2019	BUY	$2.33 - $3.79 $4,089 - $6,651	1,755 Added 156.98%	2,873 $7,000
Q4 2018 Feb 13, 2019	BUY	$2.77 - $9.38 $3,096 - $10,486	1,118 New	1,118 $3,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.